Aratana Therapeutics Inc (NASDAQ:PETX)

13.57
Delayed Data
As of May 29
 -0.13 / -0.95%
Today’s Change
9.20
Today|||52-Week Range
20.63
-23.85%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.00123.0K767.0K
 
 
 
Cost of Goods Sold0.000.0092.0K253.0K
 
 
 
Depreciation And Amortization4.0K13.0K396.0K2.0M
 
 
 
 
 
 
Operating ExpensesGross Income-4.0K-13.0K-365.0K-1.5M
 
 
 
 
 
General Expenses3.5M10.3M17.8M36.7M
 
 
 
 
 
Research And Development2.2M7.3M10.9M20.0M
 
 
 
 
 
Total Operating Expenses3.5M10.3M18.3M39.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.5M-10.3M-18.2M-38.3M
 
 
 
 
 
Extraordinary Charge0.00-1.5M-1.7M-3.4M
 
 
 
 
Interest Expense On Debt0.000.00432.0K1.1M
 
 
 
Other Expenses0.00121.0K477.0K2.3M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.5M-11.6M-19.7M-40.3M
 
 
 
 
 
Income Taxes0.000.00-15.5M-1.4M
 
 
 
Net Income-3.5M-11.6M-4.3M-38.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS11.5M11.5M11.1M29.8M
 
 
 
 
 
Shares To Calculate EPS Diluted11.5M11.5M11.1M29.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$15.43-$1.01-$0.39-$1.30
 
 
 
 
 
EPS Diluted-$0.30-$1.01-$0.39-$1.30
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account